QA: BRISTOL MYERS SQUIBB CO in us_pharma/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0000014272_2023_BRISTOL_MYERS_SQUIBB_CO.pdf

Logs

info Added remainder_ComprehensiveNetIncome directly from 10K industry.us_generic {}

Graph

Absolute values for 0000014272, BRISTOL MYERS SQUIBB CO

  xvar xval
0 AssetsCurrent 27,273,000,000
1 IntangibleAssetsNetIncludingGoodwill 57,008,000,000
2 PropertyPlantAndEquipmentNet 6,255,000,000
3 remainder_Assets 6,284,000,000
4 LiabilitiesCurrent 21,890,000,000
5 LiabilitiesNoncurrent 41,646,000,000
6 remainder_Liabilities 2,166,000,000
7 CostOfGoodsAndServicesSold 10,137,000,000
8 SellingGeneralAndAdministrativeExpense 7,814,000,000
9 ResearchAndDevelopmentExpense 9,509,000,000
10 remainder_Expenses 12,354,000,000
11 remainder_Revenues 46,159,000,000
12 remainder_NetIncome 0
13 remainder_ComprehensiveNetIncome -31,000,000
  yvar yval
0 Assets 96,820,000,000
1 Liabilities 65,702,000,000
2 Expenses 39,814,000,000
3 Revenues 46,159,000,000
4 StockholdersEquity 31,118,000,000
5 NetIncome 6,345,000,000
6 ComprehensiveNetIncome 6,329,500,000
7 BaseVar 124,263,000,000
8 EconomicCapitalRatio 0.737

Edgar->Model Mapping

Feature Distribution

Change over Time